195 related articles for article (PubMed ID: 6697321)
41. Markedly diminished drug resistance-inducing properties of vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro.
Etiévant C; Kruczynski A; Barret JM; Tait AS; Kavallaris M; Hill BT
Cancer Chemother Pharmacol; 2001 Jul; 48(1):62-70. PubMed ID: 11488526
[TBL] [Abstract][Full Text] [Related]
42. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
Coltman CA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
[TBL] [Abstract][Full Text] [Related]
43. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
Catsoulacos P; Camoutsis C; Wampler GL
Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
[TBL] [Abstract][Full Text] [Related]
44. Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
Otter GM; Sirotnak FM
Cancer Chemother Pharmacol; 1994; 33(4):286-90. PubMed ID: 8281620
[TBL] [Abstract][Full Text] [Related]
45. Vinblastine-C4 alkyl maleoyl and amino acid maleoyl derivatives. II. Experimental antitumor activity against leukemias and human tumor xenografts.
Collard MP; Rao KS; Trouet A
Anticancer Res; 1989; 9(3):625-30. PubMed ID: 2764509
[TBL] [Abstract][Full Text] [Related]
46. Effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide, a new antitumor agent with inorganic ring, on various experimental tumors.
Kitazato K; Takeda S; Unemi N
J Pharmacobiodyn; 1982 Oct; 5(10):803-10. PubMed ID: 7161708
[TBL] [Abstract][Full Text] [Related]
47. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
[TBL] [Abstract][Full Text] [Related]
48. New vinca alkaloids and related compounds.
Budman DR
Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165
[TBL] [Abstract][Full Text] [Related]
49. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
Howard SM; Theologides A; Sheppard JR
Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
[TBL] [Abstract][Full Text] [Related]
50. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
Fujimoto S; Wang Y; Inoue K; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
[TBL] [Abstract][Full Text] [Related]
51. [Antitumor and toxic effects of amotin].
Sedakova LA; Bukharova IK; Treshchalin ID; Syrkin AB
Eksp Onkol; 1987; 9(5):76-7. PubMed ID: 3691399
[TBL] [Abstract][Full Text] [Related]
52. [Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies].
Niitani H
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1495-507. PubMed ID: 10500542
[TBL] [Abstract][Full Text] [Related]
53. Vinorelbine. A review of its antitumour activity in lung cancer.
Sørensen JB
Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
[TBL] [Abstract][Full Text] [Related]
54. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.
Binet S; Chaineau E; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Int J Cancer; 1990 Aug; 46(2):262-6. PubMed ID: 2200754
[TBL] [Abstract][Full Text] [Related]
55. Preclinical antitumor activity of a new Vinca alkaloid derivative, S 12363.
Pierré A; Kraus-Berthier L; Atassi G; Cros S; Poupon MF; Lavielle G; Berlion M; Bizzari JP
Cancer Res; 1991 May; 51(9):2312-8. PubMed ID: 2015595
[TBL] [Abstract][Full Text] [Related]
56. [A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].
González Larriba JL; Alberola V; Lianes P; Panizo A; Carrato A; Muñoz Quintana A; Cardenal F; Gracia JM; Moyano A; Díaz-Rubio E
Rev Clin Esp; 1994 Nov; 194(11):953-9. PubMed ID: 7846351
[TBL] [Abstract][Full Text] [Related]
57. [Effect and role of vinca-alkaloids in the treatment of metastatic breast cancers].
Herrera A; Delgado FM; Besenval M; Merle S; Badri N; Marty M; Krikorian A
Pathol Biol (Paris); 1990 Oct; 38(8):860-1. PubMed ID: 2274391
[No Abstract] [Full Text] [Related]
58. Efficacy of 5'-nor-anhydrovinblastine (vinorelbine), against freshly explanted clonogenic human tumor cells in vitro.
Djuanda I; Depenbrock H; Peter R; Block T; Pohlmann G; Rastetter J; Hanauske AR
Invest New Drugs; 1996; 14(2):153-9. PubMed ID: 8913836
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
Leonce S; Anstett M; Combe-Perez V; Pierre A
Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
[TBL] [Abstract][Full Text] [Related]
60. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
